Categories Earnings, Health Care

Earnings Summary: Highlights of Illumina’s Q2 2023 results

Biotechnology company Illumina, Inc. (NASDAQ: ILMN) on Wednesday announced financial results for the second quarter of 2023.

  • Second-quarter revenue came in at $1.18 billion, up 1% from Q2 2022; a 3% increase on a constant currency basis
  • Net loss per share was $1.48 in Q2, compared to a loss per share of $3.40 in the year-ago quarter
  • On an adjusted basis, it was earnings of $0.32 per share for Q2 2023, compared to $0.57 per share last year
  • The company expects fiscal year 2023 consolidated revenue growth of approximately 1%
  • It is looking for a loss in the range of $2.08 per share to $1.93 per share for fiscal 2023
  • Full-year adjusted earnings per share is expected to be in the range of $0.75 to $0.90

Most Popular

NKE Earnings: Here’s everything you need to know about Nike’s Q1 report

Nike, Inc. (NYSE: NKE) on Thursday reported results for the first three months of fiscal 2024, reporting a modest rise in revenues. The sneaker giant reported net income of $1.45

Key takeaways from Accenture’s (ACN) Q4 2023 earnings report

Shares of Accenture plc (NYSE: ACN) were down 4% on Thursday after the company delivered mixed results for the fourth quarter of 2023 and provided full-year guidance that came below

CarMax (KMX) Q2 2024 Earnings: Key financials and quarterly highlights

CarMax, Inc. (NYSE: KMX) reported second quarter 2024 earnings results today. Net revenues were $7.1 billion, down 13.1% compared to the same period a year ago. Net earnings declined 5.8%

Add Comment
Viewing Highlight